Table 2.
Up-/downstaging of mediastinal lymph nodes in the patient’s cohort.
Patient | cN(CT scan) | cN(18F−FDG PET CT) | cN(invasive Biospy) | Up-/downstaging* | Location of tumor |
---|---|---|---|---|---|
1 | 2 | 2 | 2 | (Upstaging*) | Right upper lobe |
2 | 0 | 3 | 3 | Left central | |
3 | 1 | 2 | 2 | Left upper lobe | |
4 | 0 | 2 | 2 | Right upper lobe | |
5 | 1 | 2 | 2 | Middle lobe | |
6 | 2 | 0 | 0 | Right central | |
7 | 0 | 1 | 1 | Left upper lobe | |
8 | 3 | 2 | 2 | Left upper lobe | |
9 | 2 | 0 | 0 | Right central | |
10 | 1 | 3 | 3 | Left upper lobe | |
11 | 0 | 2 | 3 | Upstaging | Right upper lobe |
12 | 0 | 1 | 1 | Right lower lobe | |
13 | 0 | 1 | 0 | Downstaging | Right upper lobe |
14 | 0 | 0 | 0 | Left upper lobe | |
15 | 0 | 0 | 0 | Right upper lobe | |
16 | 0 | 0 | 0 | Left lower lobe | |
17 | 0 | 1 | 1 | Right lower lobe | |
18 | 0 | 0 | 0 | Right upper lobe | |
19 | 0 | 0 | 0 | Middle lobe |
PET: positron emission tomography.
*Upstaging from single level N2 to multilevel N2.
FGD-PET CT improves staging compared to conventional CT and enables better clinical decision-making.